The activating mutation R201C in GNAS promotes intestinal tumourigenesis in ApcMin/+ mice through activation of Wnt and ERK1/2 MAPK pathways
Open Access
- 7 June 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 29 (32), 4567-4575
- https://doi.org/10.1038/onc.2010.202
Abstract
Somatically acquired, activating mutations of GNAS, the gene encoding the stimulatory G-protein Gsα subunit, have been identified in kidney, thyroid, pituitary, leydig cell, adrenocortical and, more recently, in colorectal tumours, suggesting that mutations such as R201C may be oncogenic in these tissues. To study the role of GNAS in intestinal tumourigenesis, we placed GNAS R201C under the control of the A33-antigen promoter (Gpa33), which is almost exclusively expressed in the intestines. The GNAS R201C mutation has been shown to result in the constitutive activation of Gsα and adenylate cyclase and to lead to the autonomous synthesis of cyclic adenosine monophosphate (cAMP). Gpa33tm1(GnasR201C)Wtsi/+ mice showed significantly elevated cAMP levels and a compensatory upregulation of cAMP-specific phosphodiesterases in the intestinal epithelium. GNAS R201C alone was not sufficient to induce tumourigenesis by 12 months, but there was a significant increase in adenoma formation when Gpa33tm1(GnasR201C)Wtsi/+ mice were bred onto an ApcMin/+ background. GNAS R201C expression was associated with elevated expression of Wnt and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase (ERK1/2 MAPK) pathway target genes, increased phosphorylation of ERK1/2 MAPK and increased immunostaining for the proliferation marker Ki67. Furthermore, the effects of GNAS R201C on the Wnt pathway were additive to the inactivation of Apc. Our data strongly suggest that activating mutations of GNAS cooperate with inactivation of APC and are likely to contribute to colorectal tumourigenesis.Keywords
This publication has 54 references indexed in Scilit:
- Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide SignalingAnnual Review of Biochemistry, 2007
- Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling AxisScience, 2005
- McCune-Albright Syndrome Associated with Pituitary Microadenoma: Patient ReportJournal of Pediatric Endocrinology and Metabolism, 2004
- Thyroid Carcinoma in the McCune-Albright Syndrome: Contributory Role of Activating Gsα MutationsJournal of Clinical Endocrinology & Metabolism, 2003
- K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort StudyCarcinogenesis: Integrative Cancer Research, 2003
- Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.2003
- The murine A33 antigen is expressed at two distinct sites during development, the ICM of the blastocyst and the intestinal epitheliumMechanisms of Development, 2000
- Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouseCell, 1993
- ras oncogenes in human cancer: a review.1989
- ras GENESAnnual Review of Biochemistry, 1987